Mashup Score:55
bioRxivGermline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity - 1 week
Mashup Score:55
# bcsm
Mashup Score:23
www.esmo.orgESMO Breast Cancer 2023 - 1 week
Mashup Score:23
ESMO Breast Cancer 2023 will take place as an onsite event in Berlin, Germany, 11-13 May 2023, as well as online, through a dedicated...
-
#ESMOBreast23 📢 Are you a #youngoncologist interested in #breastcancer? Submit your clinical case for the chance to present at the YO Clinical Case Discussion Session (12/5) in Berlin 👇 Deadline: 27 March https://t.co/Z6YEanKYFe #ESMOYOC @matteolambe @kevinpunie @Rodrosb #bcsm https://t.co/Z6YEanKYFe - view on twitter
Mashup Score:18
The Jackson LaboratoryWomen in Science: Mary-Claire King - 2 days
Mashup Score:18
Mary-Claire King’s life and work serves as an ideal for scientific investigation and using our knowledge to empower...
-
For #WomensHistoryMonth, we are revisiting a profile of @uw’s Dr. Mary-Claire King and her pioneering research on the gene #BRCA1 https://t.co/3F79anlRzh #BreastCancer #bcsm https://t.co/3F79anlRzh - view on twitter
Mashup Score:14
oncologypro.esmo.orgESMO Webinar: Recurrence Risk in Early Breast Cancer: Optimal Assessment, Communication and Shared decision-making for Patients and PhysiciansChair: Christos SotiriouSpeakers: Christos Sotiriou, Giuseppe Curigliano,...
-
Resources now available with your free ESMO account 👇 'Recurrence Risk in #EarlyBreastCancer: Optimal Assessment, Communication and Shared decision-making for Patients and Physicians'. https://t.co/2Hc14wz6Hq @c_sotiriou @curijoey @CarmenCriscit #bcsm https://t.co/2Hc14wz6Hq - view on twitter
Mashup Score:12
VJOncologyImportant considerations in the management of HR+, HER2-negative early breast cancer - 2 days
Mashup Score:12
Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, provides insights and expertise on the management of HR+, HER2-negative...
-
🎥 @stolaney1 of @DanaFarberNews discusses important considerations in the management of HR+, HER2-negative early breast cancer Watch: 👉https://t.co/MU1fFEQ5zQ👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer - view on twitter
Mashup Score:9
VJOncologyRemaining questions regarding the use of frontline CDK4/6 inhibitors and endocrine therapy - 1 week
Mashup Score:9
Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, provides expert insights on remaining questions surrounding the use of...
-
Watch our latest video from #SGBCC2023 with @stolaney1 (@DanaFarberNews) who discusses remaining questions regarding the use of frontline CDK4/6i + endocrine therapy 👉https://t.co/9KBUMn6Zn4👈 @SG_BCC #BreastCancer #BCsm - view on twitter
Mashup Score:9
www.esmo.orgESMO Advanced Course on Precision Oncology in Breast Cancer 2023 - 1 week
Mashup Score:9
9-10 June 2023 –...
-
Looking to find out the latest on #PrecisionOncology in #BreastCancer? We have just the ESMO Advanced Course for you 👇 Barcelona, 9-10 June. https://t.co/Z0Cl1kXmSP @curijoey @judithbalmana @JavierCortesMD @MOliveira_MD @prat_aleix @darioT_ #bcsm #metastaticBC #TNBC #genomics https://t.co/Z0Cl1kXmSP - view on twitter
Mashup Score:9
VJOncologyWhy are we conducting clinical trials in countries that are unlikely to afford novel drugs? - 6 days
Mashup Score:9
Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, delves into a critical topic that affects not only the...
-
🎥 @stolaney1 of @DanaFarberNews talks on conducting clinical trials in countries that are unlikely to be able to afford innovative drugs Watch: 👉https://t.co/5I0wy7b7VU👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer - view on twitter
Mashup Score:8
CaringBridgeCasey | CaringBridge - 7 days
Mashup Score:8
Friends of Casey Quinlan (@MightyCasey) have known she was coping with a recurrence of her 2007 breast cancer, and it wasn’t going well. But...
-
We've started a @CaringBridge for @MightyCasey, where her support team will post updates. Subscribe to get notifications, leave words of support, share stories, etc. Anyone can view; posting requires free registration. https://t.co/0eSKSz9K0E Go holler at her! #BCSM #BeLikeLight - view on twitter
Mashup Score:7
The BreastGiven that most local relapses of breast cancer occur proximal to the original location of the primary, the delivery of additional radiation dose to...
-
Thorough, outstanding review on breast boost in the era of hypofx by Dr. Anna Kirby and team. The role of the radiation therapy breast boost in the 2020s - The Breast #bcsm https://t.co/piocOjBBak - view on twitter
More coverage:
#bcsm
Cancer represents a broad spectrum of molecularly and morphologically diverse diseases. Individuals with the same clinical diagnosis can have tumors with drastically different molecular...
Recommended preprint reading for the weekend, by @cncurtis @StanfordMed: Germline-mediated immunoediting sculpts #breastcancer subtypes and metastatic proclivity https://t.co/247vHmTXyO Brilliant work linking germline variants to epitope burden to somatic tumor evolution. #BCSM https://t.co/247vHmTXyO - view on twitter